These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30173954)

  • 1. Reply to: "Antiviral therapy in hepatitis B virus-infected immunotolerant children, exploring a new land".
    Zhao P
    J Hepatol; 2018 Nov; 69(5):1205-1206. PubMed ID: 30173954
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiviral therapy in hepatitis B virus-infected immunotolerant children, exploring a new land.
    Aly Mokhles M
    J Hepatol; 2018 Nov; 69(5):1204-1205. PubMed ID: 30177397
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotolerant children with chronic hepatitis B - To treat or not - The dilemma continues.
    Lal BB; Sood V; Khanna R; Alam S
    J Hepatol; 2018 Oct; 69(4):979-981. PubMed ID: 30093160
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to: "Immunotolerant children with chronic hepatitis B - To treat or not - The dilemma continues".
    Zhu S; Zhao P
    J Hepatol; 2018 Oct; 69(4):981-982. PubMed ID: 30086997
    [No Abstract]   [Full Text] [Related]  

  • 5. HBV: Do I treat my immunotolerant patients?
    Vlachogiannakos J; Papatheodoridis GV
    Liver Int; 2016 Jan; 36 Suppl 1():93-9. PubMed ID: 26725904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: which patients with hepatitis B virus-related hepatocellular carcinoma should receive nucleos(t)ide analogue therapy? Authors' reply.
    Wong GL; Wong VW
    Aliment Pharmacol Ther; 2016 Oct; 44(8):910. PubMed ID: 27634237
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply: 'More viral mutants, less HBsAg clearance? One size may not fit all'.
    Thompson A; Locarnini S; Revill P
    Gut; 2017 Aug; 66(8):1534-1535. PubMed ID: 27884921
    [No Abstract]   [Full Text] [Related]  

  • 8. A methodology concern of the meta-analysis of antiviral therapy for chronic hepatitis B virus infection in adults.
    Zhang ZF; Duan ZJ
    Hepatology; 2016 Sep; 64(3):1001-3. PubMed ID: 26774049
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic hepatitis B in children and adolescents.
    Paganelli M; Stephenne X; Sokal EM
    J Hepatol; 2012 Oct; 57(4):885-96. PubMed ID: 22634122
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune Responses and Hepatitis B Surface Antigen Loss After Cessation of Direct Antiviral Therapy in Hepatitis B e Antigen-Negative Patients.
    Liaw YF
    J Infect Dis; 2018 Oct; 218(11):1852-1853. PubMed ID: 29982591
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: HBsAg kinetics-guided interferon therapy for chronic hepatitis D - authors' reply.
    Niro GA; Smedile A; Andriulli A; Rizzetto M
    Aliment Pharmacol Ther; 2017 Feb; 45(3):481-482. PubMed ID: 28043094
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to: "Serum HBsAg kinetics in clinical prediction".
    Brunetto M; Cornberg M; Chan HL
    J Hepatol; 2017 Jul; 67(1):193-194. PubMed ID: 28315711
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatitis B virus e antigen plays an important role in the treatment for chronic hepatitis B].
    Kanda T; Nakamoto S; Sasaki R; Wu S
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():531-4. PubMed ID: 26845991
    [No Abstract]   [Full Text] [Related]  

  • 14. What evidence exists to support antiviral treatment in children with chronic hepatitis B?
    Iorio R; Tufano M; Giagnorio MG; Spagnuolo MI; Giannattasio A
    Antivir Ther; 2014; 19(3):225-7. PubMed ID: 24192644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon alpha therapy in HBeAg-negative chronic hepatitis B: new data in support of long-term efficacy.
    Hadziyannis SJ
    J Hepatol; 2002 Feb; 36(2):280-2. PubMed ID: 11830342
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis B virus mutation in children.
    Chang MH
    Indian J Pediatr; 2006 Sep; 73(9):803-7. PubMed ID: 17006039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of therapeutic vaccination using hepatitis B surface antigen vaccine in the immunotolerant phase of children with chronic hepatitis B infection.
    Dikici B; Bosnak M; Ucmak H; Dagli A; Ece A; Haspolat K
    J Gastroenterol Hepatol; 2003 Feb; 18(2):218-22. PubMed ID: 12542609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of interferon-alpha treatment in children with hepatitis B e antigen-positive chronic hepatitis B virus infection: a meta-analysis of follow-up for six months to two years].
    Lin ZQ; Fang F; Guo ZF; Chen Q
    Zhonghua Er Ke Za Zhi; 2007 Aug; 45(8):592-8. PubMed ID: 18021533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of chronic hepatitis B virus infection in children in Japan: a comparison of mother-to-child transmission with horizontal transmission.
    Takano T; Tajiri H; Hosono S; Inui A; Murakami J; Ushijima K; Miyoshi Y; Etani Y; Abukawa D; Suzuki M; Brooks S
    J Gastroenterol; 2017 Sep; 52(9):1041-1050. PubMed ID: 28184998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response-guided therapy by hepatitis B surface antigen level for peginterferon therapy: what is next?
    Chan HL
    J Gastroenterol Hepatol; 2012 Mar; 27(3):420-1. PubMed ID: 22353347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.